VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

Historical Holders from Q1 2014 to Q3 2025

Symbol
BIV
Type / Class
Equity / INTERMED TERM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
203M
Holdings value
$15.8B
% of all portfolios
0.113%
Grand Portfolio weight change
+0.002%
Number of holders
911
Number of buys
510
Number of sells
-329
Average Value change %
+0.01%
Average buys %
+0.014%
Average sells %
-0.006%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 203M $15.8B +$1.41B $78.09 911
2025 Q2 191M $14.8B +$379M $77.34 924
2025 Q1 186M $14.3B +$1.04B $76.57 913
2024 Q4 173M $12.9B +$1.05B $74.73 927
2024 Q3 157M $12.3B +$606M $78.37 853
2024 Q2 149M $11.2B +$338M $74.89 822
2024 Q1 143M $10.8B +$35.7M $75.40 810
2023 Q4 144M $11B +$684M $76.38 818
2023 Q3 133M $9.63B +$244M $72.31 714
2023 Q2 127M $9.56B +$971M $75.23 716
2023 Q1 114M $8.74B +$498M $76.74 696
2022 Q4 108M $8.03B +$187M $74.32 679
2022 Q3 105M $7.7B +$1.11B $73.48 648
2022 Q2 89.6M $6.96B -$95.8M $77.65 667
2022 Q1 90.8M $7.43B -$60.7M $81.90 709
2021 Q4 91M $7.97B -$159M $87.62 718
2021 Q3 90.3M $8.07B +$296M $89.44 633
2021 Q2 87.4M $7.86B +$33.3M $89.96 629
2021 Q1 87M $7.72B -$764M $88.73 618
2020 Q4 95.5M $8.86B +$129M $92.85 646
2020 Q3 92.6M $8.65B +$1.01B $93.48 558
2020 Q2 82.3M $7.67B +$344M $93.19 524
2020 Q1 78.5M $7.01B -$2.11B $89.33 492
2019 Q4 102M $8.89B +$358M $87.22 478
2019 Q3 96.9M $8.52B -$2.03M $88.00 408
2019 Q2 97M $8.39B +$276M $86.50 419
2019 Q1 93.9M $7.88B -$1.81B $83.93 396
2018 Q4 115M $9.35B +$417M $81.29 402
2018 Q3 109M $8.79B -$645M $80.48 377
2018 Q2 117M $9.48B -$1.25B $80.97 380
2018 Q1 133M $10.8B +$278M $81.77 396
2017 Q4 129M $10.8B +$601M $83.83 401
2017 Q3 121M $10.3B +$3.37B $84.66 345
2017 Q2 81.3M $6.87B -$617M $84.53 333
2017 Q1 88.6M $7.41B +$728M $83.61 331
2016 Q4 80M $6.64B -$755M $83.07 324
2016 Q3 88.4M $7.75B +$361M $87.66 312
2016 Q2 84.5M $7.44B +$1.12B $88.07 295
2016 Q1 71.5M $6.16B +$455M $86.27 276
2015 Q4 66.1M $5.49B +$806M $83.06 263
2015 Q3 54.7M $4.63B +$1.85B $84.84 231
2015 Q2 47.2M $3.96B +$269M $83.87 223
2015 Q1 44M $3.79B +$712M $86.21 218
2014 Q4 35.7M $3.03B +$154M $84.68 201
2014 Q3 31.2M $2.63B +$237M $84.26 175
2014 Q2 28.4M $2.4B +$449M $84.69 170
2014 Q1 23.1M $1.92B -$413M $83.33 161